Clinical trial
Bosentan in Children With Pulmonary Arterial Hypertension
NCT00319267 · Actelion, Industry · Completed
Key facts
| NCT number | NCT00319267 |
|---|---|
| Title | Bosentan in Children With Pulmonary Arterial Hypertension |
| Official title | An Open Label, Multicenter Study to Assess the Pharmacokinetics, Tolerability, and Safety of a Pediatric Formulation of Bosentan in Children With Idiopathic or Familial Pulmonary Arterial Hypertension |
| Acronym | FUTURE-1 |
| Lead sponsor | Actelion, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Arterial Hypertension |
| Intervention type | Drug |
| Interventions | Bosentan |
| Enrollment | 36 |
| Start date | May 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Apr 27, 2006 |
| Last update posted | Feb 3, 2025 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: